Baricitinib was generally well-tolerated. Acne was the most common adverse event (17.6%), followed by dyslipidemia (7.8%). Asthenia, elevated liver enzymes, and weight gain each occurred in fewer than ...
India Today on MSN
New hair-loss drug draws attention after trial success: Doctors break down its real impact
A new experimental hair-loss treatment has sent Cosmo Pharmaceuticals' stock soaring. But doctors say the drug is promising, ...
A. Pycnogenol® is an extract derived from French maritime pine bark. A few studies have found it helpful in easing menopausal symptoms, especially hot flashes and night sweats (Journal of Reproductive ...
Somehow, a decade into its existence, Nutrafol seems to remain peerless in the hair wellness game. Sure, there are plenty of great hair supplements out there—and ones that work, even if you have to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results